| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |